Fibrates News and Research

RSS
How lipoproteins shape your metabolic health

How lipoproteins shape your metabolic health

RNA-based therapy shows promise in reducing cholesterol and triglycerides

RNA-based therapy shows promise in reducing cholesterol and triglycerides

Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Glitazone drug use by diabetic patients associated with lower risk of primary and secondary brain cancer

Novel drug lowers triglycerides, does not reduce cardiovascular events

Novel drug lowers triglycerides, does not reduce cardiovascular events

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Fewer than 1 in 5 U.S. adults with Type 2 diabetes meet targets to reduce heart disease risk

Investigational drug reduced triglycerides in patients with severe hypertriglyceridemia, acute pancreatitis

Investigational drug reduced triglycerides in patients with severe hypertriglyceridemia, acute pancreatitis

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Could fenofibrate be an effective antiviral against SARS-CoV-2?

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

Early clinical data demonstrates the efficacy of existing drug in treating COVID-19

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Mystery underlying cardiac toxicity caused by diabetes drugs solved

Diet-induced obesity synchronizes opposing liver fat metabolic processes in mice

Diet-induced obesity synchronizes opposing liver fat metabolic processes in mice

Gene therapy offers potential cure for patients with lipoprotein lipase deficiency

Gene therapy offers potential cure for patients with lipoprotein lipase deficiency

Study findings may have critical implications to boost efficacy of T cell-based therapies

Study findings may have critical implications to boost efficacy of T cell-based therapies

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

Study evaluates link between lowering LDL-C and CV risk reduction across statin and nonstatin therapies

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

NEJM publishes positive clinical results from Phase 2 clinical study of volanesorsen

New report outlines cholesterol-targeted approach to treat people at risk for cardiovascular disease

New report outlines cholesterol-targeted approach to treat people at risk for cardiovascular disease

New research shows statins could reduce common diabetes complications

New research shows statins could reduce common diabetes complications

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Isis Pharmaceuticals begins ISIS-APOCIIIRx Phase 3 study in FCS patients

Heavy drinkers at greater risk of developing pneumonia and ARDS

Heavy drinkers at greater risk of developing pneumonia and ARDS

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Isis Pharmaceuticals reports pro forma net operating loss of $22.6 million for Q1 2014

Dezima starts DEZ-001 Phase 2b study in patients with mild dyslipidemia

Dezima starts DEZ-001 Phase 2b study in patients with mild dyslipidemia

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.